1. Introduction {#sec1}
===============

*M. celatum*, a slowly growing potentially pathogenic mycobacterium, was first described in humans in 1993 \[[@B1]\]. Its biochemical characteristics and colony morphology are similar to those of *M. avium* complex, *M. xenopi*, *M. malmoense* and *M. shimoidei* \[[@B1]\]. Three types of *M. celatum* have been identified on the basis of *16S rDNA* sequence heterogeneity \[[@B1], [@B2]\], and the possibility of having two different *16S rRNA* genes within the genome has been indicated \[[@B3]\]. Diagnostics of *M. celatum* can be challenging as the organism can be misidentified as *M. tuberculosis* due to false positive nucleic acid probe test results \[[@B4]--[@B6]\]. Unambiguous identification is, therefore, provided by mycolic acid high-performance liquid chromatography or nucleic acid sequencing \[[@B1], [@B2]\].

*M. celatum* is an uncommon cause of human infection, but it may induce invasive disease in immunocompromised hosts. It has been reported to cause infection mainly in persons affected by *AIDS* \[[@B7]--[@B11]\]. However, a growing list of reports indicates that a serious disease due to *M. celatum* may occur also in non-*HIV*-infected patients \[[@B6], [@B12]--[@B18]\].

Up to date, only three cases of *M. celatum* infection have been reported in animals: two in a domestic ferret (*Mustela putorius furo*) \[[@B19], [@B20]\] and one in a white-tailed trogon (*Trogon viridis*) \[[@B21]\].

In the present work, we report the first detection of *M. celatum* in a domestic pig (*Sus scrofa domestica*) and roe deer (*Capreolus capreolus*). In addition, a nation-wide overview of human *M. celatum* infections recorded in Slovenia between 2000 and 2010 is given.

2. Materials and Methods {#sec2}
========================

2.1. Animal Isolates {#sec2.1}
--------------------

The first isolate was obtained in 2000 from a pooled specimen of lymph nodes of pigs (*n* = 30). Granulomatous changes on the submandibular lymph nodes were visible during routine tuberculosis monitoring at slaughterhouse. The second isolate was obtained in 2010 from a roe deer in the scope of a study on tuberculosis in wild animals. No gross lesions characteristic of tuberculosis were observed on the specimens collected from roe deer ([Table 1](#tab1){ref-type="table"}).

2.2. Human Isolates {#sec2.2}
-------------------

A total of 21 *M. celatum* isolates from seven patients (two males, five females) were recorded in Slovenia in the period from 2000 to 2010. *HIV* status of the affected persons was unknown except for one patient who was confirmed to be *HIV*-negative ([Table 2(b)](#tab2){ref-type="table"}). According to the low prevalence of *AIDS* (\<0.1% in 2009) \[[@B22]\] in Slovenia and the age of the patients, *HIV* infection was regarded as unlikely for the majority of them. All the isolates were collected and identified at the National Reference Laboratory for Mycobacteria of the University Clinic Golnik in the scope of routine diagnostics of TB and diseases caused by nontuberculous mycobacteria in humans. With the exception of one, all the isolates were cultured from sputum specimens. An overview of the human isolates included in this study is shown in [Table 2(b)](#tab2){ref-type="table"}.

2.3. Histopathology {#sec2.3}
-------------------

Specimen of pig lymph nodes was subjected to Ziehl-Neelsen (ZN) and hematoxylin-eosin staining for the histopathological examination.

2.4. Bacteriology and Identification (Animal Isolates) {#sec2.4}
------------------------------------------------------

Specimen smears were ZN stained and examined microscopically for the presence of acid-fast bacilli (AFB). Specimens of animal tissues were processed according to the protocol described by Kent and Kubica \[[@B23]\] and inoculated onto the following selective media: Löwenstein-Jensen (one slant supplemented with pyruvate and one slant supplemented with glycerin), Stonebrink, Middlebrook 7H10 and BBL MGIT (Mycobacteria Growth Indicator Tube, Becton Dickinson, USA). Smears of the grown bacteria were ZN stained to confirm that they comprised AFB. Identification of the isolates was based on a combination of phenotypic characteristics and molecular methods. Growth rate, growth at different temperatures, and colony morphology were recorded. According to the phenotypic features, the isolates were subjected to PCR amplification targeting the insertion sequences characteristic of *M. avium*. DNA extracted from the selected colonies was subjected to IS*1245* and FR*300* PCR amplification employing primer sets and protocols described previously \[[@B24], [@B25]\]. In addition, a hybridization assay using GenoType Mycobacterium CM and AS culture identification kits (Hain Lifescience, Germany) was performed according to the manufacturer\'s instructions. The pig isolate was subjected to *16S rDNA* sequencing at the National Reference Center for Mycobacteria of the Research Center Borstel in Germany. To determine the phylogenetic affiliation of the roe deer isolate, PCR using mycobacteria-specific primer pair 285/264 targeting *16S rRNA* gene \[[@B26]\] was performed. Ribosomal PCR amplicons were purified from agarose gels after the electrophoretic separation using PureLink Quick Gel Extraction Kit (Invitrogen, USA) following the manufacturer\'s instructions and were sequenced in both directions (Macrogen, Korea). The retrieved sequence fragments were submitted to megablast classification accessed through NCBI website (<http://www.ncbi.nlm.nih.gov/>).

2.5. Bacteriology and Identification (Human Isolates) {#sec2.5}
-----------------------------------------------------

Specimens from humans were auramine stained and examined by fluorescent microscope for AFB. All specimens were processed according to the protocol described by Vestal \[[@B27]\] and inoculated onto two solid media (Löwenstein-Jensen and Stonebrink) and into BACTEC MGIT 960 liquid medium (Becton Dickinson, USA). The following phenotypic characteristics were investigated: growth rate, growth at different temperatures, microscopic examination of colony morphology on Middlebrook 7H10 agar plates, and biochemical activity. Biochemical tests performed are summarized in [Table 3](#tab3){ref-type="table"}. Identification with the GenoType Mycobacterium CM and AS culture identification kits (Hain Lifescience, Germany) was also performed, following the manufacturer\'s instructions. Details on the identification tests used in human isolates are given in [Table 2(b)](#tab2){ref-type="table"}.

3. Results {#sec3}
==========

3.1. Pig Isolate {#sec3.1}
----------------

Bacterial growth appeared on three of the five inoculated media ([Table 1](#tab1){ref-type="table"}). Growth was first detected after 19 days in liquid medium; nine days later, smooth filamentous ([Figure 1](#fig1){ref-type="fig"}) yellow pigmented colonies appeared on solid medium. PCR tests for *M. avium* gave negative results. Initially, the isolate was identified as a member of the genus *Mycobacterium* as diagnostic tests employed in our laboratory at the time of investigation did not enable identification of various nontuberculous mycobacteria to the species level. In 2003, GenoType Mycobacterium culture identification kit was introduced into laboratory routine work as a tool for improved identification of mycobacteria. As a result of retrospective investigation, the pig isolate was identified as *M. celatum* and was sent to the National Reference Center for Mycobacteria of the Research Center Borstel, Germany, for DNA sequencing which confirmed the isolate\'s identity (data on type were not available). Histopathological examination of the pig lymph node specimen revealed ZN negative partially incalcinated incapsulated granulomas.

3.2. Roe Deer Isolate {#sec3.2}
---------------------

Bacterial growth occurred after 34 days on three media inoculated with the lymph node material. PCR tests for *M. avium* were negative. Using GenoType Mycobacterium CM and AS culture identification kits and DNA sequencing, the isolate was identified as *M. celatum*. Sequencing showed a duplication of electropherogram peaks after the reported insertion of additional T in position 214 \[[@B3]\]. Clear sequencing patterns were obtained after manual correction that revealed the presence of two different *16S rRNA* gene copies (i.e., type 1 and type 3) in the genome of *M. celatum* ([Table 1](#tab1){ref-type="table"}).

3.3. Human Isolates {#sec3.3}
-------------------

Auramine staining generated positive results in five out of 21 specimens from which *M. celatum* was later cultivated. All smear positive specimens belonged to one patient with pulmonary disease due to *M. celatum*. The vast majority of isolates grew in liquid medium; in eight out of 21 cases, the liquid medium was the only medium in which bacterial growth was detected. Colonies that appeared on solid media were small and smooth. Until the end of 2003, the identification was based on phenotypic methods (colony morphology under stereomicroscope, biochemical tests). However, they were not discriminative enough and the isolates were identified as nonchromogenic mycobacteria. Biochemical features of the investigated isolates are shown in [Table 3](#tab3){ref-type="table"} and are consistent with the characteristics listed in the first description of the species \[[@B1]\]. GenoType Mycobacterium CM and AS culture identification kits were introduced into routine work in 2004 and have been used since for the identification of all investigated mycobacterial isolates to the species level. The isolates of unknown mycobacterial species cultured between 2000 and 2003 were identified in retrospective. The results of bacteriological and molecular investigations of the human isolates are summarized in [Table 2(b)](#tab2){ref-type="table"}.

4. Discussion {#sec4}
=============

In the first reports on *M. celatum* in animals, the organism was identified as the aetiological agent of disseminated granulomatous infections. The findings related to the infection ranged from classical tuberculous lesions with well-defined granulomas in the white-tailed trogon \[[@B21]\] to poorly defined granulomas described in the ferret \[[@B19]\]. The lesions present in the trogon were identical as those seen in classical avian mycobacteriosis caused by *M. avium* \[[@B21]\]. The route of infection was not determined although the lesions in the respiratory tract indicated transmission by inhalation \[[@B19], [@B21]\]. The source of infection was also unknown; however, as most mycobacteria are ubiquitous environmental saprophytes \[[@B28]\], exposure to soil or water seems to be the most probable source. The presence of *M. celatum* in the environment has been demonstrated by its isolation from a biofilm in an aquarium \[[@B29]\] and by the detection of *M. celatum*-like DNA sequence from the soil \[[@B30]\]. The last paper on *M. celatum* infection in animals concerns splenitis in a ferret. Common occurrence of *M. celatum* in ferrets could be explained by the supposition that they are more susceptible to mycobacterial infections as many mycobacteria, for example, *M. bovis*, *M. microti*, *M. avium*, *M. triplex*, *M. fortuitum*, *M. florentinum*, *M. interjectum*, and *M. intracellulare*, have been isolated from this animal species \[[@B31]--[@B33]\].

In the animal specimens investigated in this study, no AFB were detected by ZN staining of the tissue smears. Previous papers on *M. celatum* infection in animals report positive smear microscopy, but low numbers of AFB were recorded in some instances \[[@B20], [@B21]\]. The growth times of the bacteria from pig and roe deer were in between the growth times reported previously. Bacterial growth from the pig lymph node specimen was first detected after 19 days of incubation in liquid medium. Smooth filamentous and yellow pigmented colonies appeared after 28 days on one of the solid media. Bacterial growth from the roe deer lymph node specimen was detected in liquid and on two solid media after 34 days. For comparison, in a ferret with disseminated *M. celatum* infection, yellow colonies were visible after ten days \[[@B19]\] while small smooth and pale colonies from the ferret with splenitis appeared after eight weeks \[[@B20]\]. *M. celatum* types revealed in animals comprise type 1 in the trogon \[[@B21]\] and type 3 in the ferret with disseminated disease \[[@B19]\] while the type identified in the ferret with splenitis demonstrated close relatedness to the human *M. celatum* strains types 1 and 3 \[[@B20]\]. Our isolate from roe deer harbored two different *16S rRNA* gene copies, that is, of types 1 and 3.

The significance of *M. celatum* infection in the animals described in this paper is unclear. The presence and the location of TB-like lesions indicate that *M. celatum* is a potentially pathogenic organism for pigs which might get infected *per os*. The granulomatous changes resembled those seen in pigs infected with *M. bovis* or *M. avium*. Therefore, *M. celatum* infection might be important from the standpoint of making correct diagnosis. In roe deer specimens, there were no gross pathological changes seen on liver and the lymph nodes; histopathological examination was not performed. The finding of *M. celatum* in the lymph node tissue could be a result of ubiquitous nature of the organism, which is likely to be widespread in the environment. In both animal species, the isolation of *M. celatum* was a rare event. Among 152 mycobacteria isolated from pigs between 2000 and 2010, the majority (92.1%) belonged to *M. avium*. A few isolates of *Mycobacterium* sp., *M. terrae* and *M. fortuitum* were also detected. *M. celatum* represented 0.67% of isolates. A more detailed overview of mycobacteria in animals in Slovenia was published recently \[[@B34]\]. The mycobacteria detection rate in wild animals was lower. The national study on tuberculosis in wild animals started in 2010. During this year, a total of 108 animals of various species were sampled and eight isolates of nontuberculous mycobacteria were detected. Two out of 31 roe deer were positive for mycobacteria; one isolate was identified as *M. celatum* and another as *Mycobacterium* sp.

*M. celatum* has been mainly recognized as the causative agent of pulmonary and disseminated infections in immunocompromised humans \[[@B16]\]. It may affect also immunocompetent patients \[[@B6], [@B12], [@B16]\]; however, some authors discussed the possibility that the host\'s defense failure associated with *M. celatum* infection suggests a possible hidden immunodeficiency rather than a true immunocompetence \[[@B14]\]. The review of the literature concerning *M. celatum* infection in non-*HIV*-infected patients revealed eight reports from seven countries in the past 16 years \[[@B6], [@B12]--[@B18]\]. Among nine cases of human*M. celatum* infection, three patients had a history of pulmonary TB \[[@B14], [@B17], [@B18]\], one of TB lymphadenitis and chronic obstructive pulmonary disease \[[@B15]\], one of diabetes mellitus \[[@B13]\], and one was a lung transplant recipient \[[@B16]\] while for three patients no underlying disease was recorded \[[@B6], [@B12], [@B16]\]. In all patients, *M. celatum* caused pulmonary infection with the exception of two lymphadenitis cases in children \[[@B12], [@B16]\]. Outcome of antibiotic treatment was favorable for five out of seven adult patients while in children a surgery (in one case supported by antibiotic treatment) resulted in regression of illness \[[@B17]\]. Smear microscopy was mostly positive for AFB. The methods used for the identification of the isolates involved phenotypic and molecular methods; definitive diagnosis was provided by *16S rDNA* sequencing in the majority of cases.

During an eleven-year period, a total of 21 *M. celatum* isolates belonging to seven patients were discovered among 149,000 specimens from humans investigated in Slovenia ([Table 2(a)](#tab2){ref-type="table"}). *M. celatum* represented about 0.82% of isolates of nontuberculous mycobacteria identified between 2000 and 2010. With the exception of one isolate from bronchial aspirate, *M. celatum* isolates were cultivated from sputum. Smear microscopy (fluorescent auramine staining) was positive only in five sputa from one patient with pulmonary *M. celatum* disease. The remaining specimens were negative for AFB.

The occurrence of *M. celatum* in five patients, in which single sputum specimens were investigated, may be explained by the presence of this organism in the environment. The finding of these isolates could be regarded as random with no particular significance. In one patient, *M. celatum* was isolated from bronchial aspirate. Since bronchi are considered as a usually sterile site, the isolation of *M. celatum* from such a site could indicate the clinical importance of the infection. However, no further specimens of this 77-year-old patient were investigated. In order to meet the criteria for diagnosis of nontuberculous mycobacteria pulmonary disease, published by American Thoracic Society \[[@B35]\], several specimens should be collected within one year and evaluation of clinical and radiographic findings should be performed along with the results of bacteriology.

Therefore, among *M. celatum* isolates recovered from humans in Slovenia up to date, *M. celatum* infection was of clinical significance only in one elderly patient (born in 1929) with a history of tuberculosis (1952--1954, treated by thoracoplasty). In 2002--2003 and 2005--2006, this patient was treated also for *M. avium*-related and *M. intracellulare*-related pulmonary disease, respectively. The repeated isolation of *M. celatum* from 15 sputum specimens (among them, five smear positive) in five years confirms the clinical importance of the infection in this patient. The patient was first subjected to antibiotic therapy at the end of 2008. The outcome of the therapy is unknown as no specimens were received after the beginning of treatment course. However, the four *M. celatum* isolates obtained in 2010 and repeated therapy suggest recurrence of pulmonary infection. This case demonstrates that a preexisting lung disease represents an important risk factor for *M. celatum* pulmonary infection. This can be concluded also from the cases reported previously as the description of underlying diseases in *M. celatum*-infected patients often involved lung diseases, most frequently TB \[[@B17]\].

In conclusion, the finding of *M. celatum* in animals and humans suggests its presence in the environment. Its ability to induce TB-like lesions in pig indicates that the organism is potentially pathogenic for this animal species. In addition, *M. celatum* was recognized as the etiological agent of pulmonary infection in a patient with a history of a preexisting lung disease.

Milojka Šetina is gratefully acknowledged for skillful technical support and for conscientious archiving of mycobacterial isolates.

![Colony morphology of pig*M. celatum* isolate grown on Middlebrook 7H10 agar plates and viewed under the microscope (×100).](VMI2011-432954.001){#fig1}

###### 

Details on diagnostics of *M. celatum* isolates from animals.

  Animal           Year        Specimen        Visible lesions   Smear microscopy^2^   Growth on media          Growth time (days)   PCR            GenoType^7^    *16S rDNA* sequencing
  ---------------- ----------- --------------- ----------------- --------------------- ------------------------ -------------------- -------------- -------------- -----------------------
  Pig              2000        Submandibular   Yes               Neg^3^                LJ-G^4^, S^5^, MGIT^6^   19 (MGIT)            IS*1245* Neg   *M. celatum*   *M. celatum*^8^
  lymph nodes^1^   28 (LJ-G)   FR*300* Neg                                                                                                                         
                   34 (S)                                                                                                                                          
  Roe deer         2010        Lymph node      No                Neg                   LJ-G, S, MGIT            34 (LJ-G, S, MGIT)   IS*1245* Neg   *M. celatum*   *M. celatum*
  type 1 and 3                                                                                                                                                     
                               Liver           No                Neg                   Neg                      ---                  Neg            ---            ---

^1^Pooled specimen from 30 animals.

^2^Ziehl-Neelsen staining.

^3^Negative.

^4^Löwenstein-Jensen medium supplemented with glycerol.

^5^Stonebrink medium.

^6^Mycobacteria Growth Indicator Tube (Becton Dickinson, USA), liquid medium.

^7^GenoType Mycobacterium CM and AS culture identification kits (Hain Lifescience, Germany).

^8^Identification provided by the National Reference Center for Mycobacteria, Research Center Borstel, Germany.

###### 

\(a\) An overview of laboratory diagnostics of mycobacteria in humans in Slovenia between 2000 and 2010

  Year       No. of specimens   *M. tuberculosis*   *M. bovis*   *M. caprae*   *M. bovis* BCG   NTM^a^   *M. celatum*
  ---------- ------------------ ------------------- ------------ ------------- ---------------- -------- --------------
  2000       17016              1022                0            0             0                180      0
  2001       17576              1298                0            1             0                182      0
  2002       16062              1178                0            0             2                170      2
  2003       15236              1132                0            0             1                213      2
  2004       12268              972                 0            0             3                136      0
  2005       11556              923                 0            0             0                211      1
  2006       11753              852                 0            1             2                207      2
  2007       11995              874                 0            2             0                182      2
  2008       11566              889                 0            0             0                178      5
  2009       11855              817                 0            0             1                299      2
  2010^b^    12118              na^c^               na^c^        na^c^         na^c^            na^c^    5
                                                                                                         
  Total^b^   149001             na^c^               na^c^        na^c^         na^c^            na^c^    21

^a^Nontuberculous mycobacteria.

^b^Laboratory diagnostics of specimens received in 2010 are still ongoing; as the final reports are not yet available at the time of writing, only the number of investigated specimens is given.

^c^Not available yet.

###### 

\(b\) Details on diagnostics of *M. celatum* from humans

  Patient   Gender   Year of birth   No. of isolates   Year of isolation^1^   Sample               Microscopy^2^   Growth on media          Identification           Treatment
  --------- -------- --------------- ----------------- ---------------------- -------------------- --------------- ------------------------ ------------------------ -----------
  A         Female   1912            1                 2002                   Sputum               −^3^            LJ^6^                    CM^10^, BC^11^, GT^12^   No
  B         Female   1947            1                 2002                   Sputum               −               MGIT^7^                  CM, BC, GT               No
  C\*       Female   1929            2                 2003                   Sputum               −               MGIT                     CM, BC, GT               No
  D         Male     1959            1                 2005                   Sputum               −               MGIT                     CM, BC, GT               No
  C\*       Female   1929            2                 2006                   Sputum               −               MGIT                     CM, GT                   No
  C\*       Female   1929            2                 2007                   Sputum               ±^4^            LJ, ST^8^, MGIT          CM, GT                   No
  C\*       Female   1929            5                 2008                   Sputum               ±^5^            LJ, ST, MGIT             CM, GT                   Yes
  E         Female   1932            1                 2009                   Bronchial aspirate   −               Banič liquid medium^9^   CM, GT                   No
  F         Male     1971            1                 2009                   Sputum               −               LJ, MGIT                 CM, GT                   No
  C\*       Female   1929            4                 2010                   Sputum               −               LJ, ST, MGIT             CM, GT                   Yes
  G         Female   1974            1                 2010                   Sputum               −               MGIT                     CM, GT                   No

\*Patient with *M. celatum* pulmonary disease and a history of tuberculosis and *M. avium* and *M. intracellulare*-related pulmonary mycobacteriosis; confirmed as *HIV*-negative.

^1^No *M. celatum* isolates were identified in years 2000, 2001, and 2004.

^2^Auramin fluorescent staining.

^3^Negative.

^4^One specimen positive and one specimen negative for acid-fast bacilli.

^5^Four specimens positive and one specimen negative for acid-fast bacilli.

^6^Löwenstein-Jensen medium.

^7^Mycobacteria Growth Indicator Tube (Becton Dickinson, USA), liquid medium.

^8^Stonebrink medium.

^9^In-house liquid medium containing human serum (described in \[[@B36]\]).

^10^Colony morphology.

^11^Biochemical tests (for details, see [Table 3](#tab3){ref-type="table"}).

^12^GenoType Mycobacterium CM and AS culture identification kits (Hain Lifescience, Germany).

###### 

Results of biochemical tests performed on human *M. celatum* isolates collected between 2002 and 2005^1^.

  Test                                        Result
  ------------------------------------------- -----------------
  Semiquantitative catalase 37°C              \<45 mm of foam
  Catalase 68°C                               \+
  Tween hydrolysis (5 days/10 days)           −/−
  Arylsulfatase (3 days/14 days)              +/+
  Tellurite reduction                         \+
  Iron uptake                                 −
  Tolerance to 5% NaCl                        −
  Tolerance to TCH^2^ (10 *μ*g/mL)            \+
  Growth on MacConkey agar                    −
  Growth at 25°C                              \+
  Growth at 30°C                              \+
  Growth at 37°C                              \+
  Growth at 45°C                              −
  Growth rate                                 Slow
  Colony morphology (Middlebrook 7H10 agar)   Smooth

^1^From the beginning of 2006, identification of the isolates did not include biochemical tests any more. Five *M. celatum* isolates from the period 2002--2005, on which biochemical tests were performed, displayed uniform biochemical characteristics shown in this table.

^2^TCH: thiophene 2-carboxylic hydrazide.

[^1]: Academic Editor: Mitchell V. Palmer
